Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
17 Jul 2026 |
AP01 |
Appointment of Mr Robert William Butler as a director on 16 July 2026
|
|
|
16 Jul 2026 |
TM01 |
Termination of appointment of Dmytro Oliinyk as a director on 16 July 2026
|
|
|
20 Apr 2026 |
CS01 |
Confirmation statement made on 20 April 2026 with no updates
|
|
|
15 Aug 2025 |
AA |
Full accounts made up to 31 December 2024
|
|
|
04 Aug 2025 |
CS01 |
Confirmation statement made on 4 August 2025 with no updates
|
|
|
23 Sep 2024 |
CH03 |
Secretary's details changed for Mrs Victoria Anne Whyte on 11 September 2024
|
|
|
22 Sep 2024 |
AA |
Full accounts made up to 31 December 2023
|
|
|
17 Sep 2024 |
CH01 |
Director's details changed for Mr Paul Andrew Spear on 11 September 2024
|
|
|
17 Sep 2024 |
CH01 |
Director's details changed for Mr Dmytro Oliinyk on 11 September 2024
|
|
|
11 Sep 2024 |
AD01 |
Registered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS to 79 New Oxford Street London WC1A 1DG on 11 September 2024
|
|
|
16 Aug 2024 |
CS01 |
Confirmation statement made on 16 August 2024 with no updates
|
|
|
18 Jul 2024 |
AD02 |
Register inspection address has been changed from Glaxosmithkline 980 Great West Road Brentford Middlesex TW8 9GS England to 79 New Oxford Street London WC1A 1DG
|
|
|
08 Jul 2024 |
AP02 |
Appointment of Edinburgh Pharmaceutical Industries Limited as a director on 8 July 2024
|
|
|
20 Feb 2024 |
RESOLUTIONS |
Resolutions
-
RES13 ‐
Directors given authority to to authorise matters which may give rise to conflicts of interest 06/02/2024
-
RES10 ‐
Resolution of allotment of securities
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
20 Feb 2024 |
MA |
Memorandum and Articles of Association
|
|
|
15 Feb 2024 |
CC04 |
Statement of company's objects
|
|
|
22 Aug 2023 |
AA |
Full accounts made up to 31 December 2022
|
|
|
16 Aug 2023 |
CS01 |
Confirmation statement made on 16 August 2023 with no updates
|
|
|
16 Aug 2023 |
PSC05 |
Change of details for Glaxo Group Limited as a person with significant control on 6 June 2023
|
|
|
13 Oct 2022 |
AA |
Full accounts made up to 31 December 2021
|
|
|
18 Aug 2022 |
CS01 |
Confirmation statement made on 10 August 2022 with no updates
|
|
|
10 Mar 2022 |
AP01 |
Appointment of Mr Dmytro Oliinyk as a director on 19 February 2022
|
|
|
09 Mar 2022 |
TM01 |
Termination of appointment of Richard John Latchford as a director on 19 February 2022
|
|
|
18 Nov 2021 |
TM01 |
Termination of appointment of Erika Patteson-Brent as a director on 29 September 2021
|
|
|
04 Oct 2021 |
AA |
Full accounts made up to 31 December 2020
|
|